Market
Xeltis sharpens US market roadmap after €20.5m fundraise
Xeltis raised €20.5 million in funding to refine its US market strategy, following a €47.5 million round completed in December 2025. The Swiss biotech company, which develops bioresorbable scaffolds and regenerative medical devices, is using the capital to accelerate commercialization efforts in North America.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network